Win-win | XinBio and Linkong Pharmaceutical Service Sign a Comprehensive and Deepening Strategic Cooperation Agreement
Date：2023-04-18 Views：
On April 13th, the signing ceremony for the strategic cooperation and promotion of the fully automatic cell preparation integrated machine instrument between Suzhou XinBio Co., Ltd. and Zhengzhou Linkong Pharmaceutical Technology Service Co., Ltd. was successfully held at the new drug screening and testing platform of Zhengzhou Linkong Biomedical Park. XinBio co-founder and CEO Meng Ruifeng, co-founder and CTO Dr. Chi Shen, co-founder and CSO Zhao Guochuang, general manager and chief scientist of Linkong Pharmaceutical Service Company Chen Gang, and executive vice general manager Xue Song attended the signing ceremony. Both parties will combine their respective advantages, promote and cooperate based on fully automated closed cell preparation technology and product promotion, and cooperate in the development of antibody applications in the field of cell therapy, to promote the early establishment of a leading and highly competitive regional biopharmaceutical technology service platform in China, and strive to explore the market resources of cell therapy in Henan Province, further promoting the industrial application of cell therapy related products and the aggregation of industrial resources.
At the signing ceremony, both parties had detailed communication and exchanges on the development history, corporate culture, development overview, and cooperation planning of their respective companies. The technical application expert team provided training and practical demonstrations on the theoretical knowledge and program application of SophCyte® Kunlun Automated Cell Manufacturing System.
Recommended news
400-863-1188
Add:1st and 3rd floors of Qinghe Maker, No. 1368 Longqiao Road, Wujiang District, Suzhou City
E-mainl:info@szxxbio.com
Copyright © 2024 Suzhou XinBio Co., Ltd.
and/or its affiliates. All rights reserved.
